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Summary. Effective tools for use in control programmes against bovine leukae-
mia virus (BLV) infections require insight into the relationship between the variant
structure of the bovine leukaemia virus and the spatial-temporal interaction of
isolates and hosts. Our study showed the presence of two types of BLV isolates –
Australian and Argentine – in dairy herds from various parts of Central Argentina;
these isolates were characterised by RFLP on PCR amplicons, and some of them
were confirmed by sequencing. One genotype (Argentine) was present in all herds,
and the Australian genotype was found in two herds.
Phylogenetic analysis indicated four clusters. The first cluster was composed
of the Argentine isolates and one from Brazil; the second was composed of several
isolates found in European countries and one from Brazil; the third cluster was
composed of BLV isolates found in Japan and Germany; the fourth cluster included
American and Australian isolates and those from other countries.
The comparison of a number of synonymous and non-synonymous nucleotide
substitutions using various BLV genes revealed purifying selection, suggesting
that molecular evolution occurred under some functional constraint.
∗Nucleotide sequence data reported are available in the GenBank® databases under
the following accession numbers: AY178820 (Isolate BLV-ARGSF2); AY178818 (Isolate
BLV-ARGSF6); AY178817 (Isolate BLV-ARGSF7); AF485773 (Isolate BLV-ARGSF8);
AF485775 (Isolate BLV-ARGSF11); AY178819 (Isolate BLV-ARGSF13) and AF485774
(Isolate BLV-ASF406).
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Introduction
Bovine leukaemia virus (BLV) is an exogenous retrovirus that, together with
human T-lymphotropic virus (HTLV) and simian T-lymphotropic virus (STLV),
belongs to the deltavirus genus of the family Retroviridae [8]. Some of the
cattle infected with BLV can suffer from lymphomas and/or a proliferation of
B-lymphocytes-denominated persistent lymphocytosis, but the majority of BLV-
infected cattle are healthy carriers of the virus [23].
The genetic structure of pathogen populations is important in many contexts
(such as development of vaccines, resistance and treatments). However, the dy-
namics of virus strains are also of fundamental biological and epidemiological
interest [15]. Moreover, an important goal in studying the genetic diversity of
retroviruses is to gain a better understanding of the correlation between retrovirus
variation and disease progression [22]. At present, four complete BLV genomes
have been reported worldwide: Belgian isolate [28, 29], Japanese isolate [30],
Australian isolate [9] and recently, Argentine isolate [11]. Furthermore, knowing
whether geographical patterns of variation in a particular trait are adaptations
that arose through natural Darwinian selection or purifying selection could give
valuable information to understand polymorphism variation and to determine
candidate sites of the genotypes for functional studies.
In this study our aim was to characterise BLV isolates and their distribution
in dairy herds in Argentina. In addition, we studied whether selective advantages
of different genotypes could be introduced by purifying selection.
Materials and methods
Study population
Blood, serum and milk samples were collected from 445 lactating Holstein cows from nine
farms located in the central region of Argentina. These herds were selected based on the
owners’ willingness to collaborate in this study. All lactating cows in five of these herds were
sampled, while randomly-selected samples were taken from the other four herds. We also
used results from two herds in this study that also were included in a two-year longitudinal
study.
Serological assays
Each cow was screened with the ELISA 108 (milk and serum kit), described in [17], which
is designed to detect antibodies against gp51. After testing these samples with the PCR,
these cows were tested with the Agar Gel Immunodiffusion Test (Fac. Cs. Vet, UNLP) and a
commercial ELISA (SERELISA BLV Ab Bi Indirect, Symbiotics).
PCR assay
Oligonucleotide primers for PCR (MWG Biotech) were designed according to sequence
data published elsewhere [30]. Primers corresponding to the env gene [29] were selected,
and env5032 5′-TCT GTG CCA AGT CTC CCA GAT A-3′, and env5099 5′-CCC ACA AGG
GCG GCG CCG GTT T-3′ were used as forward primers. The reverse primers were env5521r
5′-GCG AGG CCG GGT CCA GAG CTG G-3′, env5608r 5′-AAC AAC AAC CTC TGG
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GAA GGG T-3′. The sets env5099 and env5521 had been established and described previously
[24, 25].
DNA was obtained from frozen blood collected with EDTA and was extracted using the
NucleoSpin Blood kit (Machery-Nagel). The first round of nested PCRs [12] was performed
using env5032/env5608r as first primers; initial incubation of samples was at 72 ◦C for 2 min;
denaturation took place at 94 ◦C for 2 min followed by 50 amplification cycles consisting of
denaturation at 95 ◦C, 30 s, primer annealing at 58 ◦C, 30 s and extension at 72 ◦C for
1 min; final extension took place at 72 ◦C for 4 min. The second round of amplifications
was conducted using the second pair of primers (env5099/env5521r). The second round was the
same as the first round except that the primer annealing temperature was changed to 72 ◦C. A
known positive and negative control DNA sample was included in each test run, and samples
showing a band migrating at 444 base pairs (bp) were considered as positive.
Restricted Fragment Length Polymorphism
(RFLP) protocol
Integrated BLV provirus present in the DNA of circulating leukocytes from infected animals
was compared by restriction endonuclease digestion. Randomly-selected samples (121) from
amplicons of cows that tested positive for PCR were analysed by RFLP using a series of triple
enzymes (BamHI, PvuII and BclI; Roche diagnostics GmbH) [3]. The test was done twice
on 22 samples to assess repeatability of the results. RFLP was performed using 2.5µl of the
PCR product that was digested using 0.25µl of each restriction enzyme, 1µl of buffer and
7µl of distilled water. This mix was incubated for 2.5 h at 37 ◦C for BamHI and PvuII and at
52 ◦C for BclI.
Nucleotide sequencing and analysis
In addition to RFLP analysis, 13 randomly-selected samples (of the initial 121 samples)
that were characterised by RFLP were sequenced using env-forward-primer env5099 and
env-reverse primer env5521r; both primers were modified on the 5′-end with IRD800 fluores-
cent colour. A sequencing reaction was carried out using the ThermoSequenase fluorescent-
labelled primer cycle sequencing kit with 7 deaza-dGTP. The reaction was composed of
PCR-amplicons (same primers unmodified) diluted 1:10 as template DNA and sequence
primer 1–2 pmol under the following conditions: 25 cycles using 95 ◦C, 30 sec and 60 ◦C,
30 s.
Data collection and data analyses were carried out automatically using BaseImageIRTM
software (V.4.1). Multiple sequences were aligned using the ClustalW facility of DAMBE,
V.4.0.84 [34]. Pairwise comparison of nucleotide sequence and searches for homologous DNA
sequences were performed with the program BLAST 2.1 available on the National Center
for Biotechnology Information (NCBI) website [2] using all available sequence-database
libraries. The sequences we obtained were compared with 15 sequences from GenBank®
that were included in Table 1. Four sequences (1272 D/W, 1002 D, 505 DD/W and 1137NZ)
belonging to a database from the Institute of Epidemiological Diagnostics in Wusterhausen
(Beier, personal communication), were also included in the comparison.
Base composition bias was assessed by evaluating the effective number of codons [26],
and the distribution of sequence variation was analysed using mean genetic distances within
and between clusters of isolates.
A powerful method of discriminating between positive Darwinian selection and neu-
tral polymorphism is to compare the rates of synonymous (ds) and non-synonymous (dn)
nucleotide substitutions per site (ds/dn) [26]. The null hypothesis is the neutral drift and
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Table 1. BLV isolates and genomic sequences
Isolate Background information Accession no
Sequences from GenBank®
JAP BLVCG, complete genome, Japan, 1985 K02120
AUST Australian-BLV isolate, complete genome, Australia, 1990 D00647
ARG38 ARG38 Argentine isolate, complete genome, Argentina, 2000 AF257515
D3 BLV isolate 3, env, partial cds, Germany, 1997 U87872
D15 BLV strain cow 527, env, partial cds, Germany, 1997 AF007764
D18 BLV strain cow 134, env, partial cds, Germany, 1997 AF007763
D23 BLV isolate 23, env, partial cds, Germany, 1997 U87873
VDM VdM isolate from bovine tumor, env, complete cds, 1990 M35239
LB285B LB285 isolate from bovine tumor, env, complete cds, Belgium, 1990 M35240,
FLK FLK-BLV clone pBLV 913, env, complete cds, 1990 M35242
LB59F LB59 isolate, cell line LB59Lyc, env, complete cds, France, 1990 M35238
IT2 North Italian isolate I2 isolated from blood leukocytes, env, S83530
partial cds, Italy, 1996
Bras1 BLV isolate 8513 isolated from blood leukocytes, env partial cds, AF399702
Brazil, 2001
Bras2 BLV isolate 30, env complete cds, Brazil, 2001 AF399703
Bras3 BLV isolate 384, isolated from blood leukocytes, env complete cds, AF399704
Brazil, 2001
GAGA BLV from bovine tumour DNA gag, pol and env, complete cds, M10987-K02251
Belgium, 1985
Sequences from our study
SF2 Isolate BLV-ARGSF2, env partial cds, Argentina, 1999 AY178820
SF6 Isolate BLV-ARGSF6, env partial cds, Argentina, 1999 AY178818
SF7 Isolate BLV-ARGSF7, env partial cds, Argentina, 1999 AY178817
SF8 Isolate BLV-ARGSF8, env partial cds, Argentina, 1999 AF485773
SF11 Isolate BLV-ARGSF11, env partial cds, Argentina, 1999 AF485775
SF13 Isolate BLV-ARGSF13, env partial cds, Argentina, 1999 AY178819
ASF406 Isolate BLV-ASF406, env partial cds, Argentina, 1999 AF485774
equiprobable nucleotide mutations given the specific codon at each position (neutral theory).
We analysed the ds/dn for complete alignment of env (isolates Bras2, Bras3, Arg38, VdM,
FLK, Jap, Aust, GAGA, LB59F and LB285B), pro, pol and gag (isolates Arg38, Jap, Aust and
GAGA) genes and some target areas within them. Based on overall and pairwise comparisons,
the proportions of possible nucleotide substitutions for all sites for both synonymous and
non-synonymous sites were calculated (Pamilo-Bianchi-Li-Method). Evidence of positive,
neutral or purifying selection was sought with a Z-test based on the number of synonymous
substitutions per synonymous site (KS) and the number of non-synonymous substitutions
per non-synonymous site (KN). This test evaluated whether the null hypothesis KS = KN can
be rejected in favour of one of the alternative hypotheses (positive selection for KS < KN
or purifying selection for KS > KN). The analyses were conducted using MEGA version
2.1 [19].
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Phylogenetic analysis
Only seven of our sequences - ARGSF8, ARGSF11, ASF406, ARGSF2, ARGSF6, ARGSF7
and ARGSF13 – were used for phylogenetic reconstruction because the other six were
indentical to these. Phylogenetic and molecular evolutionary analyses were conducted using
MEGA version 2.1 and PHYLIP [14]. Phylogenetic trees were constructed by a neighbour-
joining method using the Kimura Two-Parameter model (NJ) of nucleotide substitution [31].
The model assumes that there is independent change at all sites, but allows for a difference
between transition and transversion rates. The reliability of the tree was assessed by 1000
bootstrap replications and using a bootstrap confidence value (PB) of 70 % [26].
Results
Detection of BLV infected cattle
Proviral DNA was detected in whole blood samples by PCR, and antibodies were
detected in serum. Positive PCR reactions were found in 311 out of 445 animals
(70%), and 280 out of 311 (90%) of these positive reactors also tested positive
in a serological test. Moreover, 7% (31 out of 445) of the animals had negative
results in the serological test but positive results in the PCR test, probably due to
a recent infection.
Table 2 shows the sero-prevalence and PCR results, stratified by county and
herd. On most farms, high proportions of adult cows were infected. In addition,
Table 2. Distribution of BLV isolates by RFLP (n = 121) and sequencing (n = 13) according
to geographical location and herd
Country Herd Prevalence PCR RFLP (n = 121) Sequencing (n = 13)
(%)a (n)
Aust. Arg. Indef. Arg. Aust.
Rafaela
3 60 8 0 7 0 1 0
5 99 28 0 8 0 1 0
7 99 2 1 1 0 0 0
G. Roca
4 99 89 0 13 0 2 0
6 82 85 0 30 0 1 0
Susana
2 92 68 1∗ 31 0 4 0
8 nd 3 0 3 0 nd nd
B. Italia
1 4 25 1 21 1 3 1
Ataliva
9 85 3 0 3 0 nd nd
Total 311 3 117 1 12 1
∗Resulting classification did not match with sequencing
aHerd prevalence based on results from serum Blocking ELISA 108 results
nd = test not done
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we found that some infected animals consistently showed negative results to
serological tests after merging with the results of the longitudinal study.
RFLP results
The analysis of digestion products after using three restriction endonucleases
from 121 samples showed that three samples were classified as Australian type
according to the reference patterns [3] of digestion products (BamHI: 316 bp
and 128 bp; PvuII: 444 bp and BclI: 219 and 225 bp). Furthermore, 117 samples
showed a different pattern: (BamHI: 316 bp and 128 bp; PvuII: 280 bp and 164 bp
and BclI: 219 and 225 bp), which, to our knowledge, has not been published before.
Using sequencing, we could confirm that they corresponded to Argentine isolates.
Only one sample could not be classified as any known genotype based on RFLP.
The results of RFLP and sequencing, stratified according to county and herd,
are shown in Table 2. One genotype (Argentine isolates) was present in all herds,
but the other genotype (Australian isolate) was also present in two herds. Only
a single RFLP result in Herd 2 – showing an Australian pattern but a nucleotide
alignment that corresponded to ARG38 isolate – did not match the classification
using sequencing. Therefore, correspondence between RFLP and nucleotide se-
quencing results was 92%. Samples with duplicate results in RFLP (22) matched
the same characteristic pattern in both test runs (data not shown).
Sequence analysis
The RFLP patterns were confirmed by sequencing 13 samples characterised by
RFLP and comparing them with sequences available in GenBank®. Results from
the search in BLAST showed that 12 of the nucleotide sequences we obtained
exhibited high homology (E = 0.0) with BLV Arg38 isolate; identities ranged
from 99 to 100%. The remaining sequence showed high homology (E = 0.0) with
Australian BLV isolate, also with high identity (99%).
As expected, single base changes were found in some of the isolates, variations
among these sequences consisted of 20 nucleotide substitutions in total (6% of the
reported sequence), no insertions were observed and they seemed to be distributed
randomly. Most of these substitutions were located in the portion of the sequence
that belongs to the NH2 half of the gp51 protein. A few differences in the effective
number of codons used between isolates were detected, but these differences were
not significant (P > 0.05).
The deduced amino acid sequences of some of our isolates and four known
BLV isolates are compared in Fig. 1. It shows a conserved segment of gp51 (5154
to 5520) and resulted in four amino acid substitutions (67% of total substitutions);
three of them occurred in isolates from the Argentine group and one in our ASF
406. Most of these mutations were located within the peptide region that induces a
CD8+ Cytotoxic T-Cell response of the host [11] and the Proline-rich region [18].
One interesting result is that all Argentine isolates shared a substitution of
Asparagine 31 (N) (neutral-polar side) forAsparticAcid (D) (acidic) at the location
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Fig. 1. Deduced amino acid sequences of some env proteins from some of our isolates
compared to other published BLV strains: VdM – reference at top -, LB285B, ARG38,
AUST and JAP. Bullets show identical amino acids with reference sequence; amino acid
substitutions are indicated. Missing amino acids are represented by a hyphen (-). N-linked
glycosylation sites are marked in small caps. The immunostimulatory epitope for CD8 T cells
is underlined to indicate its beginning and end. ND: Neutralising Domains, underlines indicate
the beginning and end of the NDs. The framed part of the sequence represents the NH2 half of
the gp51 protein. Conformational epitope G. The shaded background shows the Proline-rich
area
of the second neutralising domain. This area was shown to be part of the receptor-
binding surface, an area which seems to be critical for receptor binding and
infection [16]. The potential glycosylation sites and cysteine residues did not
show variations.
Phylogenetic analysis of BLV isolates
The final tree obtained by using the neighbour-joining distance method is rep-
resented in Fig. 2A and shows the distance between isolates and the grouping
of isolates in 3 main clusters. Figure 2B represents the condensed tree obtained
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Fig. 2 (continued)
after bootstrapping and showed a tree that has low statistical support (PB) values
for some interior branches. With this tree we can therefore emphasize reliable
portions of the branching patterns (for topology), but branch lengths are not
proportional to the number of nucleotide substitutions. Nevertheless, it shows that
clusters observed in the original tree are well-supported. One cluster is composed
of the Argentine isolates and one of the isolates from Brazil (Brazil 3). The other
cluster is represented by several isolates found in various European countries
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Fig. 2. A Phylogenetic tree constructed using the method based on a 350 bp segment of the
env region of BLV. B Neighbour-joining consensus tree generated with MEGA2 software
using a Kimura two-parameter model. Bootstrap analysis was applied with 1000 replications;
values above 70 out of 100 are shown at the branch points
(Belgium (LB285B), Germany (D3, 1002, 1272 D/W), the northern region of
France (LB59F)) and one isolate from Brazil (Brazil1). The third cluster included
BLV isolates found in Japan and Germany (D15).
The mean distance between isolates, estimated after 1000 replications of
bootstrapping, was 0.028 ± 0.005 (SE). Table 3 summarises variability within
clusters. The higher variability of the European cluster seems to be a feature of
this group; the larger number of subgroups in Fig. 2B, supported by bootstrapping,
also reflects this variability.
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Table 3. Mean net genetic distances (d ) and SE (between
brackets) within clusters of genotypes using Kimura 2-parameter
model after 1000 bootstrapping replications
Cluster d SE
Argentine 0.004 0.002
Japan 0.000 0.000
Europe 0.014 0.005
Proportion of synonymous and non-synonymous
changes in env and pol sequences
Table 4 summarises the results of the analysis for estimating proportion of syn-
onymous (ds) and non-synonymous (dn) nucleotide substitutions per site and the
Z-test for selection testing for gag, pro, pol and env genes and several regions
within them. For gag sequences, the rates of synonymous nucleotide substitutions
per site exceeded the non-synonymous rates; this difference was statistically
significant. This pattern indicates purifying selection. The same tendency was
Table 4. Overall number of Synonymous (ds) and Non-synonymous (dn) nucleotide
substitutions per 100 sites (±SE) calculated by Pamilo-Bianchi-Li Method and Codon-based
Z-test for Tests of Selection, using different BLV genes
Gene Protein Peptides ds dn Z-test
Gag 45.0 ± 3.7 35.1 ± 2.6 ∗∗
p15 12.6 ± 2.8 2.4 ± 0.8 ∗∗
p24 28.5 ± 3.4 14.8 ± 1.9 ∗∗∗
p12 8.6 ± 3.0 0.74 ± 0.5 ∗∗
Pro 8.9 ± 2.1 2.3 ± 0.7 ∗∗
Pol 9.6 ± 0.8 1.8 ± 0.2 ∗∗∗
RNase/RT 9.8 ± 0.9 2.1 ± 0.3 ∗∗∗
Endonuclease 9.2 ± 1.3 1.2 ± 0.4 ∗∗∗
Env 6.1 ± 0.6 1.3 ± 0.2 ∗∗∗
Leader Peptide 4.6 ± 2.8 2.3 ± 1.1 NS
gp51 5.5 ± 0.9 1.3 ± 0.3 ∗∗∗
Receptor-Binding Domain 5.9 ± 1.3 1.2 ± 0.4 ∗∗
Neutralising Domains 3.8 ± 1.7 0.9 ± 0.5 NS
CD8-T Cell 9.3 ± 4.9 0.0 ± 0.0 ∗
TMHRa 4.6 ± 2.6 3.2 ± 1.1 NS
T-Helper Cell 0.0 ± 2.9 0.0 ± 0.0 NS
gp30 7.1 ± 1.2 1.2 ± 0.4 ∗∗∗
GD21 8.9 ± 3.6 0.2 ± 0.2 ∗∗
Tests to reject the null hypothesis that ds = dn: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001
NS = null hypothesis that ds = dn
aTransmembrane Hydrophobic Region
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observed for p15, p24 and p12. Similar results were observed for the protease. For
pol, rates of nucleotide substitution were estimated for the whole gene and for two
subunits (RNase/RT and endonuclease), and in each case, the rate of synonymous
substitutions per site was significantly greater than non-synonymous substitutions,
also indicating purifying selection. The pattern of nucleotide substitution seen in
the case of the env gene did not differ from the others, although there are subtle
differences in the statistical tests considering different subunits. For the main
proteins (gp51 and gp30), the results lead to similar interpretations as for the
other regions, but for the leader peptide the test indicates that there is no evidence
to reject the neutral theory.
Considering that the gp51 protein encompasses several sites that are subject
to strong interaction with the host’s immunoresponse, several important epitopes
were evaluated. The Z-test result from regions that cover the conformational
(Receptor-Binding Domain) and the immunomodulator CD8-T cell epitopes also
indicates probable purifying selection. In contrast, for the Neutralizing domains,
T-Helper cells epitope and Transmembrane Hydrophobic Region (TMHR), there
is no evidence that rejects the neutral theory. The TMHR was the only site with
rates of non-synonymous nucleotide substitutions per site that were greater than
the synonymous rates, but the difference was not statistically significant. The
results after conducting the pairwise comparison of all sequences indicate that for
gag, pro, pol and env, all pairs are submitted to purifying selection. In contrast,
the TMHR within the env gene showed that for some pairs of sequences the tests
of Selection indicate positive selection (Table 5).
Cases of persistently negative serological tests
In Herd 1, after matching results from cross-sectional and longitudinal studies,
we found that three animals that had been selected for sequencing (ARGSF7,
ARGSF8 and ASF406) were persistently infected but continually tested negative
according to serological tests. Moreover, these animals tested negative for milk
Table 5. Pairwise comparison of the number of Synonymous (ds) and Non-synonymous (dn)
nucleotide substitutions per 100 sites (±SE) calculated by Pamilo-Bianchi-Li Method and
Codon-based Z-test for Tests of Selection, for Transmembrane Hydrophobic Region of the
BLV env gene
Pair of sequences ds dn Z-test∗
Arg38-LB59B 3.0 ± 3.5 16.1 ± 5.0 ∗∗
Arg38-Aust 3.0 ± 3.5 16.1 ± 5.0 ∗∗
Arg38-FLK 3.0 ± 3.5 16.1 ± 5.0 ∗∗
GAGA-LB285F 3.0 ± 3.5 16.1 ± 5.0 ∗∗
Arg38-Jap 3.0 ± 3.5 16.1 ± 5.0 ∗∗
Arg38-VDM 3.0 ± 3.5 16.1 ± 5.0 ∗∗
∗Tests to reject the null hypothesis that ds = dn: ∗∗P < 0.05
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and serum ELISA 108 one year before and every two months for two years after
the sample was taken that appeared positive in the PCR. They were consistently
infected because the PCR was positive two years later and the RLFP results of the
different samplings were also identical (results not shown).
The analysis of the predicted amino acid showed that two of these three se-
quences (ARGSF8 andASF406) differed from the rest of the isolates in the peptide
region that induces a CD8+ Cytotoxic T-Cell response of the host. For isolate
ASF406, Proline (P) (hydrophobic–inflexible) changed to Threonine (T) (neutral-
polar side) in position 84. For ARGSF8, Isoleucine (I) (hydrophobic–aliphatic)
changed to Threonine (T) (neutral-polar side) in position 69 and Phenylalanine
(F) (hydrophobic–aromatic non-polar) changed to Isoleucine (I) (hydrophobic–
aliphatic, large non-polar) in position 82 (Fig. 1).
Discussion
We studied the RLFP and sequence variation of BLV isolates obtained from various
cattle herds in Argentina. Our results showed the presence of two types of BLV
isolates – Australian and Argentine – in dairy herds from different areas of Central
Argentina, which is one of the major dairy regions of South America. Our results
complement other studies [11] that report the presence of Argentine isolates in
other geographical areas. These findings provide firm evidence that the Argentine
isolate is the predominant isolate in cattle populations of Argentina. However, our
phylogenetical analysis shows that variation occurs within the cluster ofArgentina-
like isolates, as indicated by the isolate from Brazil (Brazil 3) [7]. This suggests
that Argentine isolates are not geographically restricted to a single country. It is
unknown if the presence of the Argentine genotype in Brazil represents a common
native variant or if this is the result of introducing infected animals fromArgentina.
Nevertheless, the phylogenetical tree shows that the Argentine clusters are clearly
different from other clusters.
We found only Argentine isolates in most of the herds we analysed except for
two herds where both types of isolates were found. The fact that we ascertained
both single and multiple genotypes on individual farms agrees with previous
findings [7, 12, 20, 27]. Unexpectedly, we found that both farms with dual isolates
were closed herds, i.e. they had not purchased replacement animals from other
farms, therefore ruling out the possibility of introducing infected cattle. Although
another study [11] pointed out the closer relationship between the Argentine and
Australian genotypes than reported in GenBank®, this fact cannot be used to
attribute the presence of these genotypes to evolutionary linkages after a single
introduction of an infected cow. Moreover, introduction of the virus via other
vectors such as hematophagous insects from neighbouring farms or contaminated
needles during mass inoculations (e.g. vaccination for foot and mouth disease)
may also explain the presence of two variants.
It is known that variations in the genotype of retroviruses in general may be
associated with changes in disease progression [22] or in differences in infectivity
between BLV strains, as was previously hypothesised [6, 11]. In our study, we
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found a different distribution of isolates and differences in prevalence. Although
our findings showed high rates of BLV infection within Argentine dairy herds,
which is in line with previous studies [1, 33], we cannot conclude that the isolates
in this study are representative strains that cause a high infection rate. The high
prevalence probably reflects the lack of a compulsory control programme and not
a high infectivity of the genotype present in the herd.
The phylogenetic data concerning genetic distances, based either on nucleo-
tides or translated amino acids, showed relatively low divergence between various
isolates, as previously reported [10, 11, 21, 27]. Nevertheless, the topology of
phylogenetical tree clearly shows that Argentine isolates represent a separate and
homogeneous group compared to other clusters. Although we could demonstrate
a detectable immune response in most infected cattle, we found some persistently
infected animals that did not show detectable antibody response. This confirms
the findings of other studies [5, 13]. One study [13] suggests that this situation
could be related to certain genotypes of the virus, but others [20] identified isolates
identical to that study, and those animals showed a detectable immunoresponse.
This could be explained by differences in the time after infection when the samples
were taken or differences in immunocompetence between the animals. We also
detected persistently infected and seronegative animals, but these animals had
different BLV genotypes. We therefore concluded that occurrence of seronegative
carriers is not related to one specific genotype.
We found one distinctive feature in two of these seronegative animals. The
amino acids substitutions were mainly clustered in the segment that is associated
with a CD8+ response of the host. Further study will be needed to determine if this
affects the three-dimensional structure and subsequently the function of a protein,
and to determine the possible relationship with seronegative carriers.
The low rate of non-synonymous substitutions compared to synonymous sub-
stitutions found in our analysis supports the hypothesis of purifying selection of
env, gag and pol genes and several subunits; consequently, molecular evolution
occurs under some functional constraint. Similar results [4, 32] were also found for
other retroviruses. These results are consistent with the low divergence between
isolates mentioned above and help to explain this distinctive feature of the BLV-
HTLV genus. Nevertheless, it appears that the TMHR is a site that might be a
good potential candidate for future functional studies.
Another striking outcome is that our interpretation of the results from selection
tests applied on the TMHR indicates that – at least for the Argentine isolate – the
host influences this site. Additional data on other Argentine genotypes are lacking,
making it difficult to evaluate determine if these results are consistent with this
genotype cluster. To link selection forces and polymorphism, our results should
be complemented with a study of the viral population within a given host that
shows fixation of such mutation [32].
In conclusion, we characterised several BLV field isolates and their distribution
in dairy herds in Argentina. Most of the isolates were represented in a BLV cluster,
but point mutations did occur. We also detected seronegative carrier animals.
Finally, we showed that selective advantages of different genotypes seem to be
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forced by purifying selection, and that this area could be an interesting topic for
future functional studies.
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